Insulin Glargine (U-100) Cartridge Systems and Pens and Orvaten
Determining the interaction of Insulin Glargine (U-100) Cartridge Systems and Pens and Orvaten and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin glargine
Brand name: Basaglar KwikPen, Lantus, Lantus Solostar Pen, Toujeo SoloStar, Lantus OptiClik Cartridge, Toujeo Max SoloStar, Lantus SoloStar
Synonyms: Insulin glargine, Insulin Glargine
Generic Name: midodrine
Brand name: Proamatine, Orvaten
Synonyms: Orvaten (Oral)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin Glargine (U-100) Cartridge Systems and Pens-Os-Cal 500+D
- Insulin Glargine (U-100) Cartridge Systems and Pens-Os-Cal 500+Extra D Chewable
- Insulin Glargine (U-100) Cartridge Systems and Pens-Os-Cal Extra D3
- Insulin Glargine (U-100) Cartridge Systems and Pens-Oscimin (Hyoscyamine Orally Disintegrating Tablets)
- Insulin Glargine (U-100) Cartridge Systems and Pens-Oscimin (Hyoscyamine Sublingual Tablets)
- Insulin Glargine (U-100) Cartridge Systems and Pens-Oscimin Oral Dispersible Tablet
- Orvaten-Insulin Glargine (U-100) Vials
- Orvaten-Insulin Glargine (U-300) Pens
- Orvaten-Insulin glargine and lixisenatide
- Orvaten-Insulin glargine and lixisenatide Subcutaneous
- Orvaten-Insulin glargine, recombinant Subcutaneous
- Orvaten-Insulin glulisine